EW Stock: Edwards Lifesciences Corporation Stock Price, Analysis & Insights
Get live ew stock price $81.89, comprehensive Edwards Lifesciences Corporation stock analysis, charts, news, and expert forecast. Real-time ew stock data and investment insights.
Loading chart...
Company Overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Company Information
- CEO
- Bernard J. Zovighian
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 15800
Contact Information
- Website
- https://www.edwards.com
- Address
- One Edwards Way
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 35.8)
Business Model & Strategy
Edwards Lifesciences Corporation operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Bernard J. Zovighian, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Edwards Lifesciences Corporation competes in the Medical - Devices within the broader Healthcare. With 48.1 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Edwards Lifesciences Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Edwards Lifesciences Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Edwards Lifesciences Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Edwards Lifesciences Corporation
- ⚠Investors should consider how Edwards Lifesciences Corporation fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 35.8) requires strong growth to justify
Market Cap
48.08B
P/E Ratio
35.76
Beta
0.97
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 48.08B market capitalization
- Trading Volume: 1.11M shares traded today
- Price Range: 52-week range of $64.89 - $87.09
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Edwards Lifesciences Corporation
Edwards Lifesciences Corporation (EW) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 48.08B, the company represents a significant player in its market. The stock is currently trading at $81.89 with a negativedaily change of 1.15%.
The company's 15800 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 35.76, beta of 0.97, and 52-week price range from $64.89 to $87.09when evaluating investment opportunities.
Why Invest in Edwards Lifesciences Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Bernard J. Zovighian
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.